CDC advisory panel to decide whether Johnson & Johnson vaccine should resume

Federal advisers will consider if injections of the single-dose J&J vaccine should resume, which would pave the way to ending a 10-day nationwide "pause."
2:31 | 04/23/21

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

Comments
Related Extras
Related Videos
Video Transcript
Transcript for CDC advisory panel to decide whether Johnson & Johnson vaccine should resume
The CDC advisory panel set to meet this morning to weigh in on the Johnson Johnson vaccine. As you notice that on hold after six women develop rare blood clots the CDC says it is also looking into new maps and guidelines. We're gonna get into that we have NIH director doctor Francis Collins the first people to Sami starts off at CDC headquarters. In Atlanta and good morning Steve. Good morning to you Michael the health officials here who are making this decision today are in a tough spot. Trying to put safety first but at the same tribe try not to scare Americans away from using these vaccines. Today is today a panel of experts put together by the CDC is expected to decide whether people should keep using. The single dose Johnson & Johnson cope it vaccine it's a key tool in ending the pandemic. But US health officials put use of the vaccine on hold last week. When six women got sick with rare blood clots after getting the shot and this morning the CDC says it's investigating a handful of new cases eighteen year old Emma perky from Clark County Nevada. Is one of the six women who struggled with blood clot after getting the vaccine a family spokesperson says she's just now starting to recover. She's improving her condition is improving. Day by day is can be long it's going to be slow. And it's going to be incremental she had several seizures days after her shocked at the hospital they had to put her in a medically induced coma. And she needed three brain surgeries. But the doctors underlined that it's not clear. If this was caused by the Johnson & Johnson vaccine despite it all her family says they still want Americans to get vaccinated the family understands that these blood clots are rear just six cases. Out of nearly seven million Americans who've gotten this particular vaccine. Keep it matters that lesson wanted to know enraged artists says smog when your reader you're right it actually getting it at lightning. Fewer Americans are now rushing to get vaccinated the daily average of shots put an arms. Is now below three million a day for the first time in weeks. And scientists have put together this map. The areas in darker blues show where Americans are resisting the vaccine the most. The panel today could make a number of recommendations they could decide to keep things the same. Or they could join European officials who have cleared the Johnson & Johnson vaccine for use but put a safety warning. Or they could say that only certain populations. Should use this vaccine.

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"2:31","description":"Federal advisers will consider if injections of the single-dose J&J vaccine should resume, which would pave the way to ending a 10-day nationwide \"pause.\"","mediaType":"default","section":"ABCNews/GMA","id":"77264078","title":"CDC advisory panel to decide whether Johnson & Johnson vaccine should resume","url":"/GMA/News/video/cdc-advisory-panel-decide-johnson-johnson-vaccine-resume-77264078"}